BioFocus Joins Argenta, Genentech Research Alliance | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Argenta, a division of Galapagos that specializes in computer-aided drug design, today said that BioFocus has joined its collaboration with Genentech to discover new chemical entities for targets picked by the biopharmaceutical firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.